Full length parathyroid hormone, PTH(1-84), for the treatment of severe osteoporosis in postmenopausal women

By Adami Silvano  

Current Medical Research and Opinion, Vol. 24, Iss. 11, 2008-11 ,pp. : 3259-3274

Informa Healthcare

Access to resources Recommend Favorite

Daily nasal spray of hPTH(1–34) for 3 months increases bone mass in osteoporotic subjects: a pilot study

By Matsumoto T.   Shiraki M.   Hagino H.   Iinuma H.   Nakamura T.  

Osteoporosis International, Vol. 17, Iss. 10, 2006-10 ,pp. : 1532-1538

Springer Publishing Company

Access to resources Recommend Favorite

Parathyroid hormone (1–84) and teriparatide in the treatment of postmenopausal osteoporosis

By Bogado1 César E   Massari2 Fabio E   Zanchetta3 José R  

Women's Health, Vol. 2, Iss. 3, 2006-05 ,pp. : 447-457

Future Medicine

Access to resources Recommend Favorite

Mechanisms for the bone anabolic effect of parathyroid hormone treatment in humans

By Aslan Derya   Andersen Mille Dahl   Gede Lene Bjerring   de Franca Tine Kellemann   Jørgensen Sara Rubek   Schwarz Peter   Jørgensen Niklas Rye  

Scandinavian Journal of Clinical and Laboratory Investigation, Vol. 72, Iss. 1, 2012-02 ,pp. : 14-22

Informa Healthcare

Access to resources Recommend Favorite

Serum Levels of 1–84 and 7–84 Parathyroid Hormone in Predialysis Patients with Chronic Renal Failure Measured by the Intact and Bio-PTH Assay

By  

Nephron Clin Pract, Vol. 102, Iss. 3-4, 2005-11 ,pp. : c108-c114

Karger

Access to resources Recommend Favorite